Bleepa agreement with CVS Equine Division

RNS Number : 4253F

Feedback PLC

16 July 2021

 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR") (which forms part of Domestic UK Law pursuant to the European Union (Withdrawal) Act 2018). With the publication of this announcement, this information is now considered to be in the public domain.

Feedback plc

Bleepa agreement with CVS Equine Division

· First private business win for Bleepa with one of UK's leading veterinary providers

· Contract covers 20 Equine surgeries and showcases new Bleepa capabilities

· Demonstrates Bleepa's value in new markets

London, 16 July 2021: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces that CVS Group ("CVS"), one of the UK's leading providers of integrated veterinary services, has appointed Bleepa as its clinical communications platform for its Equine Division.

Following a successful pilot trial, CVS has adopted Bleepa for initial use in its Equine Division.  Bleepa will be rolled-out across 20 equine specialist surgeries.  The current agreement will result in increased Bleepa users, and importantly, provides scope for a broader relationship with CVS.  Furthermore, this agreement highlights the scalability of Bleepa and the Company's ability to target non-NHS markets by tailoring the platform accordingly.

CVS has a clear vision to be the veterinary company people most want to work for by providing the best clinical care through great talent, facilities and equipment. Bleepa fits neatly into this drive to provide world-class animal care by providing their vets with its revolutionary clinical communications app. Bleepa enables vets in a field to securely connect with clinical colleagues for specialist advice and guidance whilst at the animal's side.

As part of the pilot, Feedback worked closely with the CVS team to adapt Bleepa, providing all the features needed for veterinary service, both within the surgery but also out in the field . Until now vets have not been able to easily acquire X-rays in a field and share these with colleagues. Bleepa developed an image push capability that enables X-rays to be securely pushed from the X-Ray machine over a cellular network to the Bleepa platform. The platform then makes these images available to specialists for immediate review and discussion, allowing the correct treatment guidance for the injured animal to be communicated to the vet and be provided at first visit. This capability means that images can now be taken in any location and can be instantly shared with specialist colleagues for timely advice and guidance. This technology has clear applications in both military and rural care delivery in developing countries.

Tom Oakley, CEO of Feedback, said: 

"CVS is an important partner for Feedback and we are delighted to now be working with them officially. Their validation of our technology and expertise demonstrates the flexibility of Bleepa within new markets.  By purchasing Bleepa, CVS have evidenced a real commitment to empower their vets by connecting them with specialist colleagues at the point of care, ultimately resulting in excellent animal care at the touch of a button, anywhere in the world."

Hattie Lawrence, Equine Director at CVS , said:

"We are delighted to be working with Feedback as we roll out this innovative technology across our Equine division. By introducing Bleepa, we will further enhance our clinical offering across the division and it will further enable us to give the best possible clinical care to our patients."

-Ends-

Enquiries:

Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO	[phone] [e-mail]
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai	[phone]
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus/Nick Rome/Nicholas Johnson	07980 541 893 or 07748 325 236 or 07884 664 686

Notes to editors

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.

Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

About CVS Group plc

CVS Group is one of the leading integrated veterinary service providers in the UK, the Netherlands and the Republic of Ireland. The business is focused on providing a high quality, people-led service to its customers, with outstanding and dedicated clinical teams and support staff at the core of its strategy.

The Group operates an integrated model with 528 practice sites across its three markets, including 9 specialist referral centres and 34 dedicated out-of-hours sites. Alongside Laboratories (providing diagnostic services to CVS and third parties), Crematoria (providing pet cremation and clinical waste disposal for its practices) and Animed Direct (the Group's online pharmacy and retail business).

The Group employs over 7,000 staff, including over 1,900 veterinary surgeons and over 2,300 nurses across its three territories.

 

END

 

 

MSCSFMFIIEFSELW